The effect of the contribution of clinical research coordinators in clinical trials at the Nagoya University Hospital

Hiroyuki Kamei, Tsuneko Kato, Sachiko Ando, Yukari Naruse, Mayumi Ichino, Hinako Shiraki, Sakiko Katada, Junko Kato, Kenji Miyazawa, Chisato Niide, Eri Kato, Chikako Doi, Masako Uno, Takafumi Kuzuya, Isao Muraoka, Sachiyo Ito, Hiroko Ohara, Kiyofumi Yamada, Jun Yoshida, Toshitaka NabeshimaNaoki Ishiguro

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

In order to carry out unitary management for the clinical trials of investigational drugs under Good Clinical Practice, the Center for Clinical Trial and Clinical Research was established at the Nagoya University Hospital in November 1998. Further, the clinical research coordinators (CRC) were organized in April 1999, and the general support of the clinical trial operation was started. Although it is well known that the involvement of CRC in clinical trials is necessary and important, the effect remains unclear. Thus, we evaluated the roles of CRC in the clinical trials of investigational drugs for rheumatic outpatients. The role of CRC includes assistance to obtain the informed consent, and to fill out the case report form, as well as management of the schedule. It was found that the rate of the consent acquisition from patients was significantly increased from 60.0% to 95.2% when CRC was involved. Further, the time to obtain agreement to enter into the clinical trials was significantly shortened and the rate (100.0%) of entry into the clinical trials supported by CRC was also higher than that (66.7%) in trials not supported by CRC. These results suggest that the informed consent from the patients can be obtained more easily when CRC is involved in clinical trials, and that such involvement of CRC contributes to an increase in the rate of entry of patients into the clinical trials and the speeding-up of the clinical trial enforcement.

Original languageEnglish
Pages (from-to)85-91
Number of pages7
JournalJapanese Journal of Clinical Pharmacology and Therapeutics
Volume33
Issue number3
DOIs
Publication statusPublished - 01-01-2002
Externally publishedYes

Fingerprint

Clinical Trials
Research
Investigational Drugs
Informed Consent
Appointments and Schedules
Outpatients

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Kamei, Hiroyuki ; Kato, Tsuneko ; Ando, Sachiko ; Naruse, Yukari ; Ichino, Mayumi ; Shiraki, Hinako ; Katada, Sakiko ; Kato, Junko ; Miyazawa, Kenji ; Niide, Chisato ; Kato, Eri ; Doi, Chikako ; Uno, Masako ; Kuzuya, Takafumi ; Muraoka, Isao ; Ito, Sachiyo ; Ohara, Hiroko ; Yamada, Kiyofumi ; Yoshida, Jun ; Nabeshima, Toshitaka ; Ishiguro, Naoki. / The effect of the contribution of clinical research coordinators in clinical trials at the Nagoya University Hospital. In: Japanese Journal of Clinical Pharmacology and Therapeutics. 2002 ; Vol. 33, No. 3. pp. 85-91.
@article{7f1161d37f2649d493a349d697cff4d5,
title = "The effect of the contribution of clinical research coordinators in clinical trials at the Nagoya University Hospital",
abstract = "In order to carry out unitary management for the clinical trials of investigational drugs under Good Clinical Practice, the Center for Clinical Trial and Clinical Research was established at the Nagoya University Hospital in November 1998. Further, the clinical research coordinators (CRC) were organized in April 1999, and the general support of the clinical trial operation was started. Although it is well known that the involvement of CRC in clinical trials is necessary and important, the effect remains unclear. Thus, we evaluated the roles of CRC in the clinical trials of investigational drugs for rheumatic outpatients. The role of CRC includes assistance to obtain the informed consent, and to fill out the case report form, as well as management of the schedule. It was found that the rate of the consent acquisition from patients was significantly increased from 60.0{\%} to 95.2{\%} when CRC was involved. Further, the time to obtain agreement to enter into the clinical trials was significantly shortened and the rate (100.0{\%}) of entry into the clinical trials supported by CRC was also higher than that (66.7{\%}) in trials not supported by CRC. These results suggest that the informed consent from the patients can be obtained more easily when CRC is involved in clinical trials, and that such involvement of CRC contributes to an increase in the rate of entry of patients into the clinical trials and the speeding-up of the clinical trial enforcement.",
author = "Hiroyuki Kamei and Tsuneko Kato and Sachiko Ando and Yukari Naruse and Mayumi Ichino and Hinako Shiraki and Sakiko Katada and Junko Kato and Kenji Miyazawa and Chisato Niide and Eri Kato and Chikako Doi and Masako Uno and Takafumi Kuzuya and Isao Muraoka and Sachiyo Ito and Hiroko Ohara and Kiyofumi Yamada and Jun Yoshida and Toshitaka Nabeshima and Naoki Ishiguro",
year = "2002",
month = "1",
day = "1",
doi = "10.3999/jscpt.33.3_85",
language = "English",
volume = "33",
pages = "85--91",
journal = "Japanese Journal of Clinical Pharmacology and Therapeutics",
issn = "0388-1601",
publisher = "Japanese Society of Clinical Pharmacology and Therapeutics",
number = "3",

}

Kamei, H, Kato, T, Ando, S, Naruse, Y, Ichino, M, Shiraki, H, Katada, S, Kato, J, Miyazawa, K, Niide, C, Kato, E, Doi, C, Uno, M, Kuzuya, T, Muraoka, I, Ito, S, Ohara, H, Yamada, K, Yoshida, J, Nabeshima, T & Ishiguro, N 2002, 'The effect of the contribution of clinical research coordinators in clinical trials at the Nagoya University Hospital', Japanese Journal of Clinical Pharmacology and Therapeutics, vol. 33, no. 3, pp. 85-91. https://doi.org/10.3999/jscpt.33.3_85

The effect of the contribution of clinical research coordinators in clinical trials at the Nagoya University Hospital. / Kamei, Hiroyuki; Kato, Tsuneko; Ando, Sachiko; Naruse, Yukari; Ichino, Mayumi; Shiraki, Hinako; Katada, Sakiko; Kato, Junko; Miyazawa, Kenji; Niide, Chisato; Kato, Eri; Doi, Chikako; Uno, Masako; Kuzuya, Takafumi; Muraoka, Isao; Ito, Sachiyo; Ohara, Hiroko; Yamada, Kiyofumi; Yoshida, Jun; Nabeshima, Toshitaka; Ishiguro, Naoki.

In: Japanese Journal of Clinical Pharmacology and Therapeutics, Vol. 33, No. 3, 01.01.2002, p. 85-91.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The effect of the contribution of clinical research coordinators in clinical trials at the Nagoya University Hospital

AU - Kamei, Hiroyuki

AU - Kato, Tsuneko

AU - Ando, Sachiko

AU - Naruse, Yukari

AU - Ichino, Mayumi

AU - Shiraki, Hinako

AU - Katada, Sakiko

AU - Kato, Junko

AU - Miyazawa, Kenji

AU - Niide, Chisato

AU - Kato, Eri

AU - Doi, Chikako

AU - Uno, Masako

AU - Kuzuya, Takafumi

AU - Muraoka, Isao

AU - Ito, Sachiyo

AU - Ohara, Hiroko

AU - Yamada, Kiyofumi

AU - Yoshida, Jun

AU - Nabeshima, Toshitaka

AU - Ishiguro, Naoki

PY - 2002/1/1

Y1 - 2002/1/1

N2 - In order to carry out unitary management for the clinical trials of investigational drugs under Good Clinical Practice, the Center for Clinical Trial and Clinical Research was established at the Nagoya University Hospital in November 1998. Further, the clinical research coordinators (CRC) were organized in April 1999, and the general support of the clinical trial operation was started. Although it is well known that the involvement of CRC in clinical trials is necessary and important, the effect remains unclear. Thus, we evaluated the roles of CRC in the clinical trials of investigational drugs for rheumatic outpatients. The role of CRC includes assistance to obtain the informed consent, and to fill out the case report form, as well as management of the schedule. It was found that the rate of the consent acquisition from patients was significantly increased from 60.0% to 95.2% when CRC was involved. Further, the time to obtain agreement to enter into the clinical trials was significantly shortened and the rate (100.0%) of entry into the clinical trials supported by CRC was also higher than that (66.7%) in trials not supported by CRC. These results suggest that the informed consent from the patients can be obtained more easily when CRC is involved in clinical trials, and that such involvement of CRC contributes to an increase in the rate of entry of patients into the clinical trials and the speeding-up of the clinical trial enforcement.

AB - In order to carry out unitary management for the clinical trials of investigational drugs under Good Clinical Practice, the Center for Clinical Trial and Clinical Research was established at the Nagoya University Hospital in November 1998. Further, the clinical research coordinators (CRC) were organized in April 1999, and the general support of the clinical trial operation was started. Although it is well known that the involvement of CRC in clinical trials is necessary and important, the effect remains unclear. Thus, we evaluated the roles of CRC in the clinical trials of investigational drugs for rheumatic outpatients. The role of CRC includes assistance to obtain the informed consent, and to fill out the case report form, as well as management of the schedule. It was found that the rate of the consent acquisition from patients was significantly increased from 60.0% to 95.2% when CRC was involved. Further, the time to obtain agreement to enter into the clinical trials was significantly shortened and the rate (100.0%) of entry into the clinical trials supported by CRC was also higher than that (66.7%) in trials not supported by CRC. These results suggest that the informed consent from the patients can be obtained more easily when CRC is involved in clinical trials, and that such involvement of CRC contributes to an increase in the rate of entry of patients into the clinical trials and the speeding-up of the clinical trial enforcement.

UR - http://www.scopus.com/inward/record.url?scp=0041819736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041819736&partnerID=8YFLogxK

U2 - 10.3999/jscpt.33.3_85

DO - 10.3999/jscpt.33.3_85

M3 - Review article

AN - SCOPUS:0041819736

VL - 33

SP - 85

EP - 91

JO - Japanese Journal of Clinical Pharmacology and Therapeutics

JF - Japanese Journal of Clinical Pharmacology and Therapeutics

SN - 0388-1601

IS - 3

ER -